| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1353900-92-1 | Pibrentasvir;N,N'-(((2R,5R)-1-(3,5-Difluoro-4-(4-(4-fluorophenyl)-1-piperidinyl)phenyl)-2,5-pyrrolidinediyl)bis((6-fluoro-1H-benzimidazole-5,2-diyl)-(2S)-2,1-pyrrolidinediyl((1S)-1-((1R)-1-methoxyethyl)-2-oxo-2,1-ethanediyl)))biscarbamic acid C,C'-dimethyl ester; A 1325912.0; ABT 530 | C57H65F5N10O8 |
| 1353962-25-0 | 4-Bromo-3-ethoxybenzaldehyde | C9H9BrO2 |
| 1354050-38-6 | 4-Bromo-2,6-dimethoxybenzaldehyde | C9H9BrO3 |
| 1354220-34-0 | 5-Bromo-1-(2-methoxyethyl)-1H-indazole | C10H11BrN2O |
| 1354235-96-3 | trans-Ned-19 | C30H31FN4O3 |
| 1354351-56-6 | N-((3R)-Hexahydro-1H-azepin-3-yl)carbamic acid 1,1-dimethylethyl ester | C11H22N2O2 |
| 1354486-07-9 | (3S,4S)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride (1:2) | C14H22N2.2(HCl) |
| 1354621-59-2 | (3S,4S)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine | C14H22N2 |
| 1354631-24-5 | (1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)methanone;AM 2201-pMe; MAM 2201 | C25H24FNO |
| 1354631-26-7 | 1-(5-Fluoropentyl)-N-tricyclo(3.3.1.1(3,7))dec-1-yl-1H-indole-3-carboxamide | C24H31FN2O |
| 1354638-93-9 | (3S,8R,9Z)-1,9-Pentadecadiene-4,6-diyne-3,8-diol | C15H20O2 |
| 1354691-47-6 | ((3S)-3-Hydroxy-1-pyrrolidinyl)(tetrahydro-2H-pyran-4-yl)methanone | C10H17NO3 |
| 1354744-91-4 | Naloxegol oxalate;(5alpha,6alpha)-4,5-Epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-morphinan-3,14-diol ethanedioate; AZ 13337019 oxalate; NKTR 118 oxalate | C34H53NO11.C2H2O4 |
| 1354792-85-0 | 4-Methyl-4-piperidinemethanol hydrochloride | C7H15NO.HCl |
| 1354825-58-3 | N-(2-(4-Amino-3-(4-methylphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)-2-methylpropyl)-4-pyridinecarboxamide | C22H23N7O |
| 1354959-61-7 | 3,4-Bis(trifluoromethyl)pyrrolidine hydrochloride | C6H8ClF6N |
| 1355049-97-6 | 2-Deoxy-2-fluoro-3,5-bis-O-(phenylmethyl)-D-ribonic acid gamma-lactone | C19H19FO4 |
| 1355171-47-9 | 4-(3-Hydroxy-1-pyrrolidinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C14H26N2O3 |
| 1355239-03-0 | (S)-2-(3-Fluorophenyl)pyrrolidine d-tartrate | C10H12FN.C4H6O6 |
| 1355326-21-4 | N-(2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl)-N-(3-fluorophenyl)-1H-benzimidazole-1-acetamide | C30H31FN4O2 |
| 1355326-35-0 | AGI 5198;N-(2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl)-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide | C27H31FN4O2 |
| 1355631-24-1 | 5-Chloro-4-((3,4-dichlorophenoxy)methyl)-2-fluoro-N-(methylsulfonyl)benzamide | C15H11Cl3FNO4S |
| 1355729-38-2 | Zinc difluoromethanesulfinate;Baran reagent | Zn(CHF2O2S)2 |
| 1355990-11-2 | ((((1S)-1-(3-Butyn-1-yl)hexyl)oxy)methyl)benzene | C17H24O |
| 1356019-51-6 | Bis valacyclovir;2-((2-(((9-(2-((2S)-2-amino-3-methylbutanoyl)oxyethoxymethyl)-6-oxo-1H-purin-2-yl)amino)methylamino)-6-oxo-1H-purin-9-yl)methoxy)ethyl (2S)-2-amino-3-methylbutanoate | C27H40N12O8 |
| 1356020-01-3 | (4S)-2-[[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]methyl]-5,5-dimethyl-4-thiazolidinecarboxylic Acid | C15H21N3O4S |
| 1356066-65-3 | (6-Cyano-5-fluoropyridin-3-yl)boronic acid pinacol ester;3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinonitrile | C12H14BFN2O2 |
| 1356113-40-0 | 2-Chloro-5-fluoro-4-(trifluoromethyl)pyridine | C6H2ClF4N |
| 1356400-78-6 | 2-(Dimethylamino)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | C15H22BNO3 |
| 1356565-46-2 | Imatinib Impurity 8;N-(2-methyl-5-(4-((4-methylpiperazin-1-yl)methyl)benzamido)phenyl)-4-((4-methylpiperazin-1-yl)methyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)benzamide | C42H47N9O2 |
| 1356837-89-2 | Perindopril EP Impurity E;Perindoprilat Isopropyl Ester | C20H34N2O5 |
| 1356841-89-8 | Tacrolimus-13C;(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-((1E)-2-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl-3-13C-d2)-15,19-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone | C44H67D2NO12 |
| 1356906-17-6 | 2-(2-(2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethoxy)ethoxy)ethanol | C25H33N3O4S |
| 1356929-58-2 | Perindopril-d4;(2S,3aS,7aS)-1-((2S)-2,3,3,3-tetradeuterio-2-(((2S)-1-ethoxy-1-oxopentan-2-yl)amino)propanoyl)-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid | C19D4H28N2O5 |
| 1356933-89-5 | L-(+)-Ergothioneine-d3;5-((2S)-2-carboxy-2-(dimethyl(trideuteriomethyl)azaniumyl)ethyl)-1H-imidazole-2-thiolate | C9H15N3O2S |
| 1356962-20-3 | N-(4-(4-Amino-1-piperidinyl)-2-methoxyphenyl)-5-chloro-4-(1H-indol-3-yl)-2-pyrimidinamine | C24H25ClN6O |
| 1356963-01-3 | 2-Methoxy-5-methyl-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline | C18H30N4O |
| 1357072-61-7 | 3-((2-Methyl-2H-indazol-5-yl)thio)-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazine;c-Met inhibitor | C17H14N8S |
| 1357078-03-5 | B-(2-Oxo-2H-1-benzopyran-7-yl)boronic Acid | C9H7BO4 |
| 1357160-72-5 | URB 937 | C20H22N2O4 |
| 1357171-62-0 | N-((1,1'-Biphenyl)-4-ylmethyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine;ML 228 | C27H21N5 |
| 1357289-08-7 | 1-(2,2-Dimethoxyethyl)-1,4-dihydro-4-oxo-3-(phenylmethoxy)-2,5-pyridinedicarboxylic acid 2,5-dimethyl ester | C20H23NO8 |
| 1357289-29-2 | Dolutegravir Impurity B;Dolutegravir RR isomer;(3R,7R)-N-((2,4-difluorophenyl)methyl)-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo(8.4.0.03,8)tetradeca-10,13-diene-13-carboxamide | C20H19F2N3O5 |
| 1357302-64-7 | 4'-((1R,2S)-2-Aminocyclopropyl)biphenyl-3-ol | C15H15NO |
| 1357351-29-1 | 6-Hydroxy-2-(hydroxymethyl)-2-methyl-2H-naphtho(1,2-b)pyran-5-carboxylic acid methyl ester | C17H16O5 |
| 1357353-58-2 | 2-Methyl-4-pyridinemethanamine hydrochloride (1:2) | C7H10N2.2(HCl) |
| 1357389-11-7 | (2E)-N-(2-Amino-4-fluorophenyl)-3-(1-(3-phenyl-2-propen-1-yl)-1H-pyrazol-4-yl)-2-propenamide;RGFP 966 | C21H19FN4O |
| 1357470-29-1 | 8-Cyclopentyl-7,8-dihydro-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-7-oxo-pyrido(2,3-d)pyrimidine-6-carbonitrile;ON 123300 | C24H27N7O |
| 1357471-44-3 | Methanol, compd. with N1-1-naphthalenyl-1,2-ethanediamine, hydrochloride (1:1:2) | C12H14N2.CH4O.2(HCl) |
| 1357503-31-1 | 1-(Azidosulfonyl)-1H-imidazol-3-ium tetrafluoroborate;N-diazo-1H-imidazol-3-ium-3-sulfonamide tetrafluoroborate | C3H4BF4N5O2S |